These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1365 related items for PubMed ID: 18532993

  • 1. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):385-96. PubMed ID: 18532993
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
    Wilhelm SM, Brubaker CM, Varcak EA, Kale-Pradhan PB.
    Pharmacotherapy; 2008 Apr 15; 28(4):496-505. PubMed ID: 18363533
    [Abstract] [Full Text] [Related]

  • 3. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.
    J Clin Gastroenterol; 2008 Sep 15; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [Abstract] [Full Text] [Related]

  • 4. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M.
    J Clin Gastroenterol; 2008 Sep 15; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [Abstract] [Full Text] [Related]

  • 5. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 6. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y, Ringel-Kulka T.
    J Clin Gastroenterol; 2011 Nov 15; 45 Suppl():S145-8. PubMed ID: 21992954
    [Abstract] [Full Text] [Related]

  • 7. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 15; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 8. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
    Brenner DM, Chey WD.
    Rev Gastroenterol Disord; 2009 Mar 15; 9(1):7-15. PubMed ID: 19367213
    [Abstract] [Full Text] [Related]

  • 9. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct 15; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 10. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):387-94. PubMed ID: 16128676
    [Abstract] [Full Text] [Related]

  • 11. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
    Kajander K, Korpela R.
    Asia Pac J Clin Nutr; 2006 Sep 01; 15(4):576-80. PubMed ID: 17077079
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):994-1002. PubMed ID: 18671775
    [Abstract] [Full Text] [Related]

  • 13. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):48-57. PubMed ID: 17919270
    [Abstract] [Full Text] [Related]

  • 14. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L, Elia C, Navino M, Cisarò F, ARMONIA Study Group.
    Acta Biomed; 2007 Aug 01; 78(2):111-6. PubMed ID: 17933278
    [Abstract] [Full Text] [Related]

  • 15. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
    Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D, Symbiotic Study Group.
    Minerva Gastroenterol Dietol; 2006 Dec 01; 52(4):349-58. PubMed ID: 17108864
    [Abstract] [Full Text] [Related]

  • 16. Probiotics and functional gastrointestinal disorders in children.
    Vandenplas Y, Benninga M.
    J Pediatr Gastroenterol Nutr; 2009 Apr 01; 48 Suppl 2():S107-9. PubMed ID: 19300120
    [Abstract] [Full Text] [Related]

  • 17. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
    Cuomo R, Savarese MF, Gargano R.
    Dig Dis; 2007 Apr 01; 25(3):241-4. PubMed ID: 17827948
    [Abstract] [Full Text] [Related]

  • 18. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
    Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR.
    Aliment Pharmacol Ther; 2009 Mar 01; 29(5):508-18. PubMed ID: 19053980
    [Abstract] [Full Text] [Related]

  • 19. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S, Mora D, Gschwender M, Popp K.
    Aliment Pharmacol Ther; 2011 May 01; 33(10):1123-32. PubMed ID: 21418261
    [Abstract] [Full Text] [Related]

  • 20. Probiotics in functional gastrointestinal disorders: what are the facts?
    Quigley EM.
    Curr Opin Pharmacol; 2008 Dec 01; 8(6):704-8. PubMed ID: 18775516
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 69.